Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.


Each year, 500,000 patients are treated with radiotherapy for head and neck cancer, resulting in relatively high survival rates. However, in 40% of patients, quality of life is severely compromised because of radiation-induced impairment of salivary gland function and consequent xerostomia (dry mouth). New radiation treatment technologies enable sparing of… (More)
DOI: 10.1126/scitranslmed.aac4441


6 Figures and Tables

Blog articles referencing this paper